This is consistent with a study in bladder cancer, where knockdown of Cdk6 and SIRT-1 (direct targets of miR-34a) was not as effective reversing cisplatin resistance as miR-34a restoration[18]. Here, SIRT1 is linked to urinary bladder cancer.